Related Experiment Video
Updated: Nov 16, 2025

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses
Published on: November 21, 2023
A review: Epidemiology, pathogenesis and prospect in developing vaccines for novel Coronavirus (COVID-19)
1Department of Biotechnology, Radha Govind University, Ramgarh, 829122 Jharkhand, India.
Insights
The COVID-19 pandemic, caused by a novel coronavirus, has led to millions of cases and deaths globally. Ongoing research focuses on developing vaccines and therapeutics to control the spread of this infectious disease.
Area of Science:
- * Virology and Epidemiology
- * Public Health and Infectious Disease Control
- * Vaccine Development and Therapeutics
Background:
- * Emergence of a novel coronavirus (COVID-19) in Wuhan, China, in December 2019.
- * Rapid global spread leading to a World Health Organization (WHO) declared pandemic.
- * Significant impact on global health, with millions of cases and deaths.
Purpose of the Study:
- * To review current research and advances in vaccine and therapeutic design against COVID-19.
- * To highlight the epidemiology, transmission dynamics, and control strategies for COVID-19.
- * To discuss future directions in managing infectious disease outbreaks.
Main Methods:
- * Review of ongoing scientific literature and research on COVID-19.
- * Analysis of epidemiological data and transmission patterns.
- * Examination of vaccine and therapeutic development efforts targeting the coronavirus spike (S) protein.
Main Results:
- * High transmissibility of COVID-19 through person-to-person droplet transmission.
- * Significant global health emergency status declared by WHO.
- * Ongoing efforts to develop effective vaccines and treatments, with millions of cases and deaths reported.
Conclusions:
- * The COVID-19 pandemic necessitates urgent development of vaccines and therapeutics.
- * Understanding epidemiology and transmission is crucial for effective control measures.
- * Continued research is vital for future preparedness against infectious diseases.
Abstract:
In December 2019, a large number of coronavirus cases were emerged in Wuhan, Hubei Province, China and rapidly spread to different countries and territories around the world within four months. The World Health Organization (WHO) declared this outbreak as a global health emergency. The spread of COVID-19 over globe is highly contagious; they transmitted from person-to-person through small droplets of infected person. Many diagnosis and treatment methods have been implemented to reduce and control the outbreak. Efforts have been made to develop coronavirus vaccine against S protein or spike glycoprotein of coronavirus. COVID-19 outbreak will affect the Gross Domestic Product (GDP) of the world. At the time of preparing manuscript, total number of active cases reaches to more than 8.9 million and confirmed death reaches to approx. 4.6 lakh. This article highlights the ongoing research and advances in designing vaccine and therapeutics against COVID-19 and also focusing on the epidemiology, transmission, future direction and control the spread of infectious diseases.
More Related Videos
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Vaccinations
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pneumonia II: Pathophysiology

